Michiels Cédéric F, Van Hove Cor E, Martinet Wim, De Meyer Guido R Y, Fransen Paul
Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
Laboratory of Pharmacology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
Eur J Pharmacol. 2014 Sep 5;738:170-8. doi: 10.1016/j.ejphar.2014.05.036. Epub 2014 Jun 2.
L-type calcium channel blockers (LCCBs) reduce blood pressure more effectively in hypertensive than in normotensive subjects and are more effective in vascular smooth muscle (VSM) than in cardiac muscle. This has been explained by the depolarized resting potential of VSM in comparison with heart muscle cells and during hypertension, because both favor the "high affinity" inactivated state of the L-type calcium channel (LCC). Depolarized resting potentials, however, also increase Ca(2+) influx via window, non-inactivating LCC. The present study investigated whether these channels can be effectively blocked by nifedipine, verapamil or diltiazem, as representatives of different LCCB classes. C57Bl6 mouse aortic segments were depolarized by 50mM K(+) to attain similar degree of inactivation. The depolarization evoked biphasic contractions with the slow force component displaying higher sensitivity to LCCBs than the fast component. Removal of the fast force component increased, whereas stimulation of Ca(2+) influx with the dihydropyridine BAY K8644, a structural analog of nifedipine, decreased the efficacy of the LCCBs. Addition of LCCBs during the contraction caused concentration-dependent relaxation, which was independent of the presence of a fast force component, but still showed lower sensitivity in the presence of BAY K8644. Our data suggest that steady-state contractions by depolarization with 50mM K(+) are completely due to window Ca(2+) influx, which is preferentially inhibited by LCCBs. Furthermore, results point to interactions between the LCCB receptors and Ca(2+) ions or BAY K8644. The high affinity for open, non-inactivating LCC may play a dominant role in the anti-hypertensive effects of LCCBs.
L型钙通道阻滞剂(LCCBs)在高血压患者中降低血压的效果比在血压正常的受试者中更显著,并且在血管平滑肌(VSM)中比在心肌中更有效。与心肌细胞相比,VSM的静息电位在高血压期间会发生去极化,这一点已被用来解释上述现象,因为这两种情况都有利于L型钙通道(LCC)处于“高亲和力”失活状态。然而,去极化的静息电位也会通过窗口(即非失活的LCC)增加Ca(2+)内流。本研究调查了作为不同类LCCB代表的硝苯地平、维拉帕米或地尔硫䓬是否能有效阻断这些通道。将C57Bl6小鼠主动脉段用50mM K(+)去极化,以达到相似的失活程度。去极化引发双相收缩,其中缓慢的力量成分对LCCBs的敏感性高于快速成分。去除快速力量成分会增强LCCBs的效果,而用硝苯地平的结构类似物二氢吡啶BAY K8644刺激Ca(2+)内流则会降低LCCBs的效果。在收缩过程中添加LCCBs会引起浓度依赖性舒张,这与快速力量成分的存在无关,但在BAY K8644存在的情况下仍表现出较低的敏感性。我们的数据表明,用50mM K(+)去极化引起的稳态收缩完全是由于窗口Ca(2+)内流,而LCCBs能优先抑制这种内流。此外,结果表明LCCB受体与Ca(2+)离子或BAY K8644之间存在相互作用。对开放的、非失活的LCC的高亲和力可能在LCCBs的抗高血压作用中起主导作用。